-
effectivehealthcare.ahrq.gov/sites/default/files/johnson_-ahrq-mcda-presentation.pdf
August 27, 2012 - Institute. www.rti.org
The Use of Conjoint Analysis to Elicit
Patient Preferences in Selecting
Treatment … Preferences among treatment alternatives depend on
the relative importance of features. … Respondents state preferences for series of
constructed, hypothetical treatment alternatives … A Treatment B
PAIN
STIFFNESS
STOMACH
PROBLEMS
Occasional mild … Treatment preferences and medication adherence of people
with type 2 diabetes using oral glucose-lowering
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_executive.pdf
October 01, 2007 - Effectiveness Reviews,
the program supports systematic
appraisals of existing scientific
evidence regarding treatments … Among PCI-assigned patients, use
of stents and adjunctive medical therapy (e.g., dual
antiplatelet therapy … Medicine, Angioplasty, or Surgery Study (MASS-II): a randomized, controlled
clinical trial of three therapeutic … with diabetes was reported
by 6 RCTs … Comparative effectiveness by adjunctive therapies
Adjunctive therapies Weak - RCTs did not provide comparative
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-stents-outcomes_research.pdf
January 01, 2010 - Late thrombosis in drug-eluting
coronary stents after discontinuation of
antiplatelet therapy. … Males
Females
Age >= 75
Age < 75
Off Label
No Diabetes
Diabetes / non-insulin dep
Diabetes / insulin … Males
Females
Age >= 75
Age < 75
Off Label
No Diabetes
Diabetes / non-insulin dep
Diabetes / insulin … Males
Females
Age >= 75
Age < 75
Off Label
No Diabetes
Diabetes / non-insulin dep
Diabetes / insulin … Males
Females
Age >= 75
Age < 75
Off Label
No Diabetes
Diabetes / non-insulin dep
Diabetes / insulin
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/effect-dietary-digestible-disposition-comments_0.pdf
March 03, 2025 - Report
Title: Association of Digestible Carbohydrate Intake With Cardiovascular Disease, Type 2
Diabetes … Association of Digestible
Carbohydrate Intake With Cardiovascular Disease, Type 2 Diabetes, Obesity, … The
numbers of adolescents with type II diabetes are increasing
and certainly many of these disease … treatment/management due
to the widespread prevalence of overweight, obesity,
prediabetes and type … ,
pre-diabetes, and
overweight/obesity.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_surveillance.pdf
April 01, 2016 - How do the efficacy, effectiveness, or harms of treatment with
nonpharmacologic treatments for TRD … summarize, interventions included for one or more of the key questions (KQs) are:
• Nonpharmacologic therapies … Key Question 5:
How do the efficacy, effectiveness, or harms of treatment with nonpharmacologic treatments … How do the efficacy, effectiveness, or harms of treatment with nonpharmacologic treatments for TRD differ … How do the efficacy, effectiveness, or harms of treatment with nonpharmacologic treatments for TRD differ
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/hypertensive-disorders-pregnancy-protocol-amendment.pdf
April 20, 2022 - Rates of HDP are
rising in the U.S.,2 likely due to increased prevalence of pre-existing HTN, obesity, diabetes … the hypothesized reasons
for the disparities relate to differential incidence of risk factors (e.g., diabetes … for HTN or HDP administered postpartum
o Antihypertensive medications (single or combination therapies … For KQ 3, RCTs that compare MgSO4 with placebo, no treatment, or
non-MgSO4 treatments (which are not … Therapy with both magnesium sulfate and nifedipine
does not increase the risk of serious magnesium-related
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0496_12-30-2011.pdf
January 01, 2011 - requiring
the use of contrast media; subgroups of interest include patients with renal dysfunction
or diabetes … (serum creatinine or creatinine clearance),
mortality, rate of renal recovery, adverse effects of treatment … What is the comparative efficacy of different therapies in preventing contrast-
induced nephropathy? … factor
for CIN, chronic kidney disease, is rising, driven in part by the increasing prevalence of diabetes
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-adults_research-protocol.pdf
December 01, 2010 - benefits in many outcome domains,9 and newer medications are
replacing the conventional antipsychotics as treatments … Second-Generation
Antipsychotics
(Monotherapy)
Second-Generation
antipsychotics
(Combination Therapy … treatment in the context of previous episodes, and treatment resistance. … age, sex, race,
weight, height, body mass index, comorbidities, use of concurrent standard medical
therapies … Phenothiazines/ad, to, tu, ct, po, ae
[Administration & Dosage, Toxicity, Therapeutic
Use, Contraindications
-
effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-summary.pdf
April 01, 2020 - , but less applicable to selecting among
nonopioid treatments. … also reviewed evidence that
may help inform decisions regarding prioritization
of nonopioid drug therapies … by clinicians and
patients when selecting therapy. … Opioid Treatments
for Chronic Pain: A Systematic Review. … Noninvasive Nonpharmacologic
Treatments for Chronic Pain: An Update.
-
effectivehealthcare.ahrq.gov/health-topics/diabetic-eye-problems
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-533_05-24-2013.pdf
January 01, 2013 - type 1 diabetes mellitus;
3. iron deficiency anemia (IDA);
4. osteoporosis?
b. … asymptomatic, at-risk populations (affected family members, patients with
type 1 diabetes);
iii. … follow-up testing;
iii. invasive procedures (biopsies);
iv. cases diagnosed;
v. patients complying with treatment … ; and
vi. response to treatment.
5.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-infertility_research-protocol.pdf
September 02, 2016 - "[Mesh]
OR "Endometriosis/therapy"[Mesh] OR "Nutrition Therapy"[Mesh] OR "Weight Loss"[Mesh]
OR "Exercise … use”[MeSH] OR “Aspartic
Acid/therapeutic use”[MeSH] OR “Citrulline/therapeutic use”[MeSH] OR
“Flavonoids … /therapeutic use”[MeSH] OR “Adrenal Cortex Hormones”[MeSH] OR “Ejaculatory
Ducts/therapy”[MeSH] OR " … infertility, other female causes of infertility, or common
comorbidities such as hypertension and diabetes … infertility, other female causes of
infertility, or common comorbidities such as hypertension and diabetes
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0262_05-11-2007.pdf
January 01, 2007 - What constitutes an adequate diagnostic evaluation on which to base treatment of
UI?
2. … How effective is pharmacologic treatment of UI?
3. … How effective is non-pharmacologic treatment of UI?
4. … Does this make a clinical difference in response to treatment?
8. … factors
Prostate disorders
Dementia
Psychiatric disorders, specifically depression
Diabetes
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-2015.pdf
January 01, 2015 - recently and will be used in place of existing treatments
in some patients and as an addition to treatment … The drug was FDA approved for treatment of type 2
diabetes in 2010, and was FDA approved for treating … for
type 2 diabetes. … Hypertension Therapeutic device $1,000,000,000 $500,000,000
Lomitapide (Juxtapid) for Treatment … of
Diabetes Implant $256,000,000 $256,000,000
Fluocinolone Acetonide Implant (Iluvien) for Treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/stem-cell-children_executive.pdf
February 01, 2012 - Effectiveness
Reviews, the program supports
systematic appraisals of existing
scientific evidence regarding
treatments … Treatment,
therapy, or
intervention
-HSCT
Intermediate Outcomes
• Recurrence-free survival
• … Treatment,
therapy, or
intervention
-HSCT
Intermediate Outcomes
Slowing of the progression of or … Treatment,
therapy, or
intervention
-HSCT
Intermediate Outcomes
• Stable source of endogenous … selection to the past 15 years to ensure that we identified
evidence that is comparable in terms of therapeutic
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/evidence-gaps-for-mhealth-tools-in-diabetes
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-adherence-interventions_research-protocol.pdf
August 18, 2011 - Although medical researchers have demonstrated many
efficacious medical treatments to improve health … actual treatment outcomes. … Diabetes Care 2001 Jan;24(1):124-30. PMID: 11194217.
8. … Adherence to Long Term Therapies:
Evidence for Action. … Adherence to combination antiretroviral therapies in
HIV patients of low health literacy.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-anxiety-children_0.pdf
October 01, 2018 - This tool was based on a previously
developed and tested decision aid for diabetes.11 The structure, … design, and themes of the
diabetes cards were modified to fit the needs of patients with anxiety and … address recently approved treatments. … Furthermore, if these clinics have an established first line treatment such as group therapy;
implementation … The
diabetes mellitus medication choice decision aid:
a randomized trial.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_executive.pdf
September 01, 2013 - for PCI (two studies), diabetes mellitus
(two studies), and chronic kidney disease (one study). … All
seven were based on randomized trials comparing
clopidogrel-based treatment with alternative therapies … The treatment comparisons were between standard-dose
clopidogrel-based therapy and high-dose clopidogrel … Given the availability of
several therapeutic options for antiplatelet treatment (e.g.,
increasing … Patients
receiving different antiplatelet therapies whose choice
of treatment was not based on CYP2C19
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/infertility_research-protocol.pdf
October 12, 2015 - , with 34.6 percent of couples having both
male and female diagnoses.15
Available Treatments: Treatment … Syndrome/therapy"[Mesh]!
OR!"Endometriosis/therapy"[Mesh]!OR!"Nutrition!Therapy"[Mesh]!OR!"Weight! … “Arginine/therapeutic!use”[MeSH]!OR!“Aspartic!
Acid/therapeutic!use”[MeSH]!OR! … “Citrulline/therapeutic!use”[MeSH]!OR!
“Flavonoids/therapeutic!use”[MeSH]!OR!“Adrenal!Cortex! … Ducts/therapy”[MeSH]!OR!"Varicocele/surgery"[Mesh]!OR!“Laser!Therapy”[MeSH]!OR!